The method, called the PEPPER-Margin-DeepVariant, analyzes data for Oxford Nanopore sequencers, one of the fastest commercial sequencing technologies available, according to a Jan. 13 company blog post.
On Jan. 12, the New England Journal of Medicine published a study led by the Stanford (Calif.) University School of Medicine demonstrating the method’s use in a newborn intensive care unit. The method was used to analyze genomic data for 12 patients, and the researchers gave five diagnoses based on its analysis, allowing for more timely and disease-specific treatment.
In the fastest cases, a suspected disease-causing genomic variant was identified less than eight hours after sequencing began, compared with the previous record of 13.5 hours.
Google’s post said new methods for genome sequencing data analysis can lead to breakthroughs. To further explore how its machine-learning technology can improve the field, the tech giant has partnered with Pacific Biosciences, a genomic sequence platform developer, to create more genome sequencing initiatives.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
